Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2004 Jun 11;18(4):231–236. doi: 10.1002/jcla.20028

Urinary protein fraction in healthy subjects using cellulose acetate membrane electrophoresis followed by colloidal silver staining

Ryoko Machii 1, Ryo Kubota 2, Nobuo Hiratsuka 1, Kayo Sugimoto 1, Rie Masudo 1, Yuriko Kurihara 1, Shizuko Kobayashi 2, Kiyoko Shiba 1,
PMCID: PMC6807772  PMID: 15202115

Abstract

We previously reported a rapid and highly sensitive colloidal silver staining solution suitable for the cellulose acetate membrane. This method was useful for detecting even very small amounts of urinary protein. In the present study, we examined urinary protein fractions in healthy subjects, using cellulose acetate membrane electrophoresis (CAE) with a highly sensitive colloidal silver staining, in an attempt to determine the clinical relevance of urinary protein fractions. Sixty unconcentrated spot urine specimens were analyzed by CAE and calculated by densitometry. All of the samples were separated into five fractions by CAE. The mean±1 SD of the percentage of five fractions was 28.37±8.51 in albumin, 4.30±4.19 in α1‐globulin, 14.41±6.14 in α2‐globulin, 19.45±7.10 in β‐globulin, and 33.46±8.24 in γ‐globulin. The albumin/globulin (A/G) ratio was 0.41±0.17. These six items and the concentrations of total protein, albumin, and β‐N‐acetyl‐d‐glucosaminidase (NAG) did not significantly differ between males and females. NAG is the marker of tubulointerstitial nephropathy. The results suggest that there are no gender‐dependent differences in the urinary protein fractions of healthy subjects. J. Clin. Lab. Anal. 18:231–236, 2004. © 2004 Wiley‐Liss, Inc.

Keywords: cellulose acetate membrane electrophoresis, healthy subjects, colloidal silver staining, urinary protein

REFERENCES

  • 1. Hiratsuka N, Shiba K, Shinomura K, et al. Urinary protein fractions in healthy subjects using CAE followed by staining with acid violet 17. Biol Pharm Bull 1994;17:1355–1357. [DOI] [PubMed] [Google Scholar]
  • 2. Shiba KS, Kanamori K, Harada T, et al. A cause of discrepancy between values for urinary protein as assayed by the Coomassie brilliant blue G‐250 method and the sulfosalicylic acid method. Clin Chem 1985;31:1215–1218. [PubMed] [Google Scholar]
  • 3. Matsuda K, Hiratsuka N, Shiba K. Sensitive method for detection and semiquantification of Bence Jones protein by cellulose acetate membrane electrophoresis using colloidal silver staining. Clin Chem 2001;47:763–766. [PubMed] [Google Scholar]
  • 4. Kubota R, Machii R, Hiratsuka N, Shiba K. Cellulose acetate membrane electrophoresis in the analysis of urinary proteins in patients with tubulointerstitial nephritis. J Clin Lab Anal 2003;17:44–51. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Machii R, Matsuda K, Hiratsuka N, Sugimoto K, Shiba K. Analysis of an expanded width of albumin fraction by cellulose acetate membrane electrophoresis in IgA nephropathy urine before treatment. J Clin Lab Anal 2003;17:37–43. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. Zager RA. Urinary protein markers of tubulointerstitial nephritis. Invest Urol 1980;18:197–202. [PubMed] [Google Scholar]
  • 7. Guder WG, Ivandic M, Hofmann W. Physiopathology of proteinuria and laboratory diagnostic strategy based on single protein analysis. Clin Chem Lab Med 1998;36:935–939. [DOI] [PubMed] [Google Scholar]
  • 8. Ivandic M, Hofmann W, Guder WG. The use of knowledge‐based systems to improve medical knowledge about urine analysis. Clin Chim Acta 2000;297:251–260. [DOI] [PubMed] [Google Scholar]
  • 9. Ivandic M, Hofmann W, Guder WG. Urinary Protein Expert System (UPES) Homepage. München, Germany: Institute of Clinical Chemistry, Municipal Hospital München‐Bogenhausen. http://wilas.zait.uni‐bremen.de/upes/main.htm.
  • 10. Matsuda K, Hiratsuka N, Shiba K. Semiquantitative analysis of urinary low protein levels using silver dot blot assay. J Clin Lab Anal 2001;15:171–174. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Tamm I, Horsfall FL Jr. Characterization and separation of an inhibitor of viral hemagglutination present in urine. Proc Soc Exp Med 1950;74:108–114. [PubMed] [Google Scholar]
  • 12. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. J Clin Chem Clin Biochem 1983;21:709–720. [DOI] [PubMed] [Google Scholar]
  • 13. Huang Z‐Q, Sanders PW. Biochemical interaction between Tamm‐Horsfall glycoprotein and Ig light chains in the pathogenesis of cast nephropathy. Lab Invest 1995;73:810–817. [PubMed] [Google Scholar]
  • 14. Rodhes DCJ, Hinsman EJ, Rodhes JA. Tamm‐Horsfall glycoprotein binds IgG with high affinity. Kidney Int 1993;44:1014–1021. [DOI] [PubMed] [Google Scholar]
  • 15. Huang Z‐Q, Sanders PW. Localization of a single binding site for immunoglobulin light chains on human Tamm‐Horsfall glycoprotein. J Clin Invest 1997;99:732–736. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES